Explore the latest in ADHD, including advances in understanding its epidemiology, etiology, diagnosis, and treatment.
This cohort study of Tennessee Medicaid enrollees from 1999 through 2014 investigates the risk of unexpected death among children and youths aged 5 through 24 years without psychosis who are new users of antipsychotic medications compared with new users of control medications.
This population-based study evaluates the presence of attention-deficit/hyperactivity disorder and autism spectrum disorder in later-born siblings of children with one of these disorders.
This population-based study examines the association between genetic risk variants for neuropsychiatric disorders and the age at onset and trajectories of depression in children.
This Viewpoint explains differences between attention-deficit/hyperactivity disorder symptoms and impairments and suggests that treatment approaches must address both aspects of the disorder.
This survey study uses data from the National Health Interview Survey to examine changes in the prevalence of diagnosed attention-deficit/hyperactivity disorder (ADHD) in US children and adolescents over a 20-year period, from 1997 to 2016.
This cross-sectional analysis of US Medicaid files from 29 states investigates the prevalence of and risk factors associated with concurrent stimulant and opioid use among Medicaid-enrolled adults with attention-deficit/hyperactivity disorder.
This population-based cohort study examines the association between gestational age at birth and symptoms of attention-deficit/hyperactivity disorder among children at 5 and 8 years of age and possible sex differences in the associations.
This systemic review and meta-analysis examines the association between hypertensive disorders of pregnancy and risk of neurodevelopmental disorders in offspring.
This cohort study uses data from the Nurses Health Study II to assess the risk of attention-deficit/hyperactivity disorder among grandchildren of women exposed to diethylstilbestrol during pregnancy.
This pharmacoepidemiology study uses 1999-2014 NHANES data to characterize trends in use of prescription medications among children and adolescents aged 0 to 19 years in the United States.
This cohort study compares the development of secondary attention-deficit/hyperactivity disorder in children who were previously hospitalized with traumatic brain injury vs children previously hospitalized with orthopedic injury.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: